Brind.
  1. LSE resumed trading of its receipts on July 4, 2026, involving pharmaceutical peers like Beximco Pharma.

Salman F Rahman, vice chairman of Beximco Pharma, plans to resign from the company's board.

3 reports, 2 independent Updated Oct 7
Gone quiet
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Salman F Rahman, vice chairman of Beximco Pharma, plans to resign from the company's board.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Salman F Rahman lost his board positions at Beximco Group.1 source
  2. Salman F Rahman plans to resign from Beximco Pharma board, which is listed on the LSE.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story